Minerva Neurosciences
NERV
#9462
Rank
โ‚น13.21 B
Marketcap
โ‚น276.75
Share price
-9.12%
Change (1 day)
23.37%
Change (1 year)

Minerva Neurosciences (NERV) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚น29.53 Billion

According to Minerva Neurosciences 's latest financial reports the company's total liabilities are โ‚น29.53 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Minerva Neurosciences - Total liabilities on balance sheet (from 2013 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น21.42 B297.54%
2024-12-31โ‚น5.39 B-24.14%
2023-12-31โ‚น7.10 B14.33%
2022-12-31โ‚น6.21 B20.77%
2021-12-31โ‚น5.14 B1317.77%
2020-12-31โ‚น0.36 B-89.76%
2019-12-31โ‚น3.54 B3.76%
2018-12-31โ‚น3.41 B2.72%
2017-12-31โ‚น3.32 B81.58%
2016-12-31โ‚น1.83 B1.15%
2015-12-31โ‚น1.81 B68.61%
2014-12-31โ‚น1.07 B93.32%
2013-12-31โ‚น0.55 B5233.77%
2012-12-31โ‚น10.41 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Incyte
INCY
โ‚น146.34 B 395.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
โ‚น39.48 B 33.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Clovis Oncology
CLVS
โ‚น73.22 B 147.95%๐Ÿ‡บ๐Ÿ‡ธ USA